Home › Legal basis for Global Health EDCTP3 Joint Undertaking adopted
Legal basis for Global Health EDCTP3 Joint Undertaking adopted
19 November 2021
The European Commission today announced the adoption of 10 European Partnerships set up between the European Union, Member States and/or the industry, including the Global Health EDCTP3 Partnership. The EU will provide nearly €10 billion of funding that the partnerships will match with at least an equivalent amount of investment.
Today, the General Affairs Council adopted the Regulation, the Single Basic Act, for setting up nine Joint Undertakings, including the Global Health EDCTP3 Partnership. Yesterday, the General Affairs Council adopted the Decision for the Metrology Partnership. The 10 Partnerships adopted cover the areas of health, transport, energy, digital technology and metrology.
Under the new legal basis, the 10 European Institutionalised Partnerships will start the set-up and implementation process, where recruitment of staff, appointment of advisory bodies and adoption of work programmes are only some of the tasks ahead. Once set up, the different Joint Undertakings will launch calls for proposals, select and finance research and innovation projects in line with their objectives.
About Global Health EDCTP3
The Global Health EDCTP3 Joint Undertaking – the third programme of the European & Developing Countries Clinical Trials Partnership (EDCTP) – is a partnership between the European Union and the European and Developing Countries Clinical Trials Partnership (EDCTP) Association, whose members are several EU Member States and Associated countries and several African countries. The partnership builds on the first and second European and Developing Countries Clinical Trials Partnership (EDCTP) programmes and will support international research partnerships accelerating the clinical evaluation of drugs, vaccines and diagnostics for key infectious diseases affecting sub-Saharan Africa, as well as novel approaches for surveillance and control of emerging/re-emerging infections. It will also strengthen clinical research capacity in the region. Building on the two previous EDCTP programmes, the Partnership will ensure that more people gain access to new medical interventions and help to protect regional and global health security.
Background on European Partnerships
The European Partnerships are key implementation tools of Horizon Europe the EU research and innovation programme (2021-2027) and aim to improve and accelerate the development and uptake of new innovative solutions across different sectors, by mobilising public and private resources. By bringing private and public partners together, European Partnerships help to avoid the duplication of investments and contribute to reducing the fragmentation of the research and innovation landscape in the EU.
We use cookies on our website to enhance your browsing experience, analyze site traffic, and personalize content. By clicking "Accept All," you consent to the use of all cookies. However, you may visit "Cookie Settings" to provide controlled consent.